Interleukin 10 is a growth factor for a population of regulatory T cells
Open Access
- 1 February 1998
- Vol. 42 (2) , 157-158
- https://doi.org/10.1136/gut.42.2.157
Abstract
The paper by Groux et al sheds some light on how IL-10 (generally thought of as an immunosuppressive cytokine) may act to regulate intestinal inflammation. The authors show that repetitive antigenic stimulations in vitro of human and murine CD4+ cells in the presence of IL-10 results in the generation of a T cell subset with low proliferative capacity which secretes high levels of IL-10 and interferon γ (IFN-γ) and has immune regulatory activities both in vitro and in vivo. These cells, which the authors term T regulatory 1 cells (Tr1), exhibit a cytokine profile distinct from previously described Th1, Th2 and Th0 subsets of CD4+ T cells.Keywords
This publication has 11 references indexed in Scilit:
- Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients.The Journal of Immunology, 1997
- A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells.The Journal of Experimental Medicine, 1996
- Transforming growth factor beta: the good, the bad, and the ugly.The Journal of Experimental Medicine, 1994
- Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice.The Journal of Experimental Medicine, 1994
- Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid miceInternational Immunology, 1993
- Spontaneous development of inflammatory bowel disease in T cell receptor mutant miceCell, 1993
- Interleukin-10-deficient mice develop chronic enterocolitisCell, 1993
- Ulcerative colitis-like disease in mice with a disrupted interleukin-2 geneCell, 1993
- CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells.The Journal of Experimental Medicine, 1993
- T-cell subsets in autoimmunityCurrent Opinion in Immunology, 1992